Gallbladder (GB) carcinoma, although relatively rare, is the most common biliary tree
cholangiocarcinoma with aggressiveness and poor prognosis. It is closely associated with …

Introduction Benchmarking in surgery has been proposed as a means to compare results
across institutions to establish best practices. We sought to define benchmark values for …

Background Indicators of surgical outcomes are designed to objectively evaluate surgical
performance, enabling comparisons among surgeons and institutions. In recent years, there …

Background The rarity yet high malignancy of gallbladder adenocarcinoma (GBA) endows it
with a distinctive nature. Radical resection remains the foremost therapeutic approach for …

Background Level I evidence for multi-modality management of gallbladder cancers (GBC)
is evolving. Methods Prospectively maintained operative GBC database of 1307 patients …

Purpose To investigate the effectiveness of neoadjuvant therapy and lymph node dissection
(LND) on overall survival (OS) in patients with stage III/IV gallbladder cancer without distant …

We congratulate Yan et al. for this interesting paper, investigating the correlation of
circulating tumor cells (CTC) and survival in locally advanced/metastatic gallbladder cancer …

We appreciate the thoughtful insights provided by Zhang et al. in response to our
article,“Benchmark and Geographic Differences in Gallbladder Cancer Surgery: An …

Delivering top-notch oncologic care is not just a matter of having a steady hand or using a
specific approach. It takes a rigorous commitment to quality and performance. The …

We read with interest the article by Vega et al. entitled “Benchmark and Geographic
Differences in Gallbladder Cancer Surgery: An International Multicenter Study”. 1 The …